Summary:
In-Quest Medical Research is conducting a study on efficacy and safety of semaglutide once weekly verses insulin glarine once daily as add to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes.
Qualified Participants Must:
• Be 18 years of age or older
•
Be Insulin-naïve, diagnosed with type 2 diabetes and on a stable treatment of metformin or metformin and a sulphonylurea medication
•
Have your hemoglobin A1c between 7.0 – 10%
Qualified Participants May Receive:
If you qualify, you will receive all study-related care and study medication at no cost to you. Reimbursement for time and travel costs may be provided.